BHG NYSE
Bright Health Group, Inc.
1W: +13.6%
1M: -28.8%
3M: +12.5%
1Y: -88.2%
$16.35
Last traded 2024-02-20 — delisted
Overview
News
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Dividends
Analysis
Technicals
Weather
Peers
ESG
Institutions
Dark Pool
Short Interest
Revenue Segmentation
By Product / Service
Revenue by Segment (5-Year Trend)
Income Trends
Revenue
$937M
-19.3% ▼
5Y CAGR: +27.3%
Gross Profit
$195M
+258.2% ▲
5Y CAGR: +28.1%
Operating Income
-$102M
+83.7% ▲
Net Income
-$186M
+84.5% ▲
EPS (Diluted)
$-22.65
+85.0% ▲
EBITDA
-$149M
+73.6% ▲
Profit Margins
Year-over-Year Growth
View Full Income Statement
| Line Item | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 |
|---|---|---|---|---|---|
| Revenue | $1.2B | $4.0B | $2.4B | $1.2B | $937M |
| YoY Growth | +330.2% | +233.7% | -40.1% | -51.9% | -19.3% |
| Cost of Revenue | $1.0B | $4.0B | $2.2B | $1.3B | $742M |
| Gross Profit | $160M | $76M | $206M | -$123M | $195M |
| Gross Margin | 13.3% | 1.9% | 8.5% | -10.6% | 20.8% |
| R&D Expenses | $19M | $0 | $0 | $0 | $0 |
| SG&A Expenses | $309M | $914M | $584M | $0 | $0 |
| Operating Expenses | $418M | $1.3B | $682M | $1.7B | $1.0B |
| Operating Income | -$258M | -$1.2B | -$477M | -$628M | -$102M |
| Operating Margin | -21.3% | -29.7% | -19.8% | -54.1% | -10.9% |
| Interest Expense | $0 | $8M | $13M | $38M | $19M |
| Income Before Tax | -$258M | -$1.2B | -$634M | -$629M | -$99M |
| Tax Expense | -$9M | -$27M | $4M | -$1M | $3M |
| Net Income | -$248M | -$1.2B | -$638M | -$1.2B | -$186M |
| Net Margin | -20.6% | -29.2% | -26.4% | -103.4% | -19.9% |
| EPS (Diluted) | $-145.94 | $-240.33 | $-81.08 | $-150.94 | $-22.65 |
| EBITDA | -$249M | -$1.2B | -$557M | -$567M | -$149M |
| Shares Outstanding | 2M | 5M | 8M | 8M | 8M |